What is NDC 0093-1025?

0093-1025 is the product NDC for Nefazodone Hydrochloride, Nefazodone hydrochloride 200 mg/1 tablet, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Nefazodone Hydrochloride?

5 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Nefazodone Hydrochloride NDC 0093-1025

NDC codes

FDA NDC Directory

Product NDC (as listed)0093-1025Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00093-1025Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0093-1025-06	00093102506	60 TABLET in 1 BOTTLE (0093-1025-06)Marketed from Sep 16, 2003

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Nefazodone Hydrochloride
Generic name (nonproprietary): nefazodone hydrochloride
Active ingredients: Nefazodone hydrochloride — 200 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Teva Pharmaceuticals USA, Inc.NDC labeler code 0093
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076037
Marketing start: Sep 16, 2003
Listing expires: Dec 31, 2026
Identifiers: Product ID 0093-1025_11cdc932-271c-4988-aad9-076340888bceSPL ID 11cdc932-271c-4988-aad9-076340888bceSPL set ID 51ff7db5-aaf9-4c3c-86e6-958ebf16b60fRxCUI 1098649, 1098666, 1098670, 1098674, 1098678UNII 27X63J94GRUPC 0300931024060, 0300937113065
Pharmacologic class: Serotonin Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400093102506 followed by a unit qualifier and the quantity

Package 00093-1025-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 31, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Nefazodone hydrochloride tablets are indicated for the treatment of depression. When deciding among the alternative treatments available for this condition, the prescriber should consider the risk of hepatic failure associated with nefazodone hydrochloride treatment (see WARNINGS ). In many cases, this would lead to the conclusion that other drugs should be tried first. The efficacy of nefazodone in the treatment of depression was established in 6 to 8 week controlled trials of outpatients and in a 6 week controlled trial of depressed inpatients whose diagnoses corresponded most closely to the DSM-III or DSM-IIIR category of major depressive disorder (see CLINICAL PHARM…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0093-1025

What is NDC 0093-1025?: 0093-1025 is the product NDC for Nefazodone Hydrochloride, Nefazodone hydrochloride 200 mg/1 tablet, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Nefazodone Hydrochloride.
What is the active ingredient?: Nefazodone hydrochloride.
Who is the labeler?: Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Nefazodone Hydrochloride?: 5 other product NDCs are listed under this name. See all Nefazodone Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Nefazodone Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Nefazodone Hydrochloride	Nefazodone hydrochloride 100 mg/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0093-1024	00093-1024-06
Nefazodone Hydrochloride	Nefazodone hydrochloride 250 mg/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0093-1026	00093-1026-06
Nefazodone Hydrochloride	Nefazodone hydrochloride 150 mg/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0093-7113	00093-7113-06
Nefazodone Hydrochloride	Nefazodone hydrochloride 50 mg/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0093-7178	00093-7178-01
Nefazodone Hydrochloride	Nefazodone hydrochloride 150 mg/1	TabletOral	Bryant Ranch Prepack	63629-7046	63629-7046-0163629-7046-0263629-7046-03+1 more

Other NDCs under ANDA 076037

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076037
Product	Strength	Form · route	Labeler	Product NDC
Nefazodone Hydrochloride	Nefazodone hydrochloride 100 mg/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0093-1024
Nefazodone Hydrochloride	Nefazodone hydrochloride 250 mg/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0093-1026
Nefazodone Hydrochloride	Nefazodone hydrochloride 150 mg/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0093-7113
Nefazodone Hydrochloride	Nefazodone hydrochloride 50 mg/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0093-7178
Nefazodone Hydrochloride	Nefazodone hydrochloride 150 mg/1	TabletOral	Bryant Ranch Prepack	63629-7046